Clinical Research Directory
Browse clinical research sites, groups, and studies.
Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.
Sponsor: University Hospital, Lille
Summary
This study evaluates the potential interest of a new multi-lumen infusion access device (Edelvaiss® Multiline NEO) in the prevention of catheter-related bacteremia when administering injectable drugs in premature infants. This device will be compared to the standard infusion set of each center.
Official title: Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants: Randomized Controlled Multicenter Study of Edelvaiss Multiline NEO Device
Key Details
Gender
All
Age Range
24 Weeks - 29 Weeks
Study Type
INTERVENTIONAL
Enrollment
87
Start Date
2016-01
Completion Date
2020-05
Last Updated
2026-04-22
Healthy Volunteers
Yes
Conditions
Interventions
Edelvaiss Multiline NEO
Use of Edelvaiss Multiline NEO to infuse the parenteral nutrition and drugs during the study period
Standard Infusion Set
Use of Standard Infusion Set to infuse the parenteral nutrition and drugs during the study period
Locations (4)
Chu Amiens Picardie
Amiens, France
Hôpital Côte de Nacre - CHU de Caen
Caen, France
Hôpital Jeanne de Flandre - CHRU de Lille
Lille, France
Hôpital Charles Nicolle - CHU de Rouen
Rouen, France